Subtotal gland resection for MR negative Cushing disease with no detectable tumor on gland exploration: operative video.
Cushing disease
neurosurgery
pituitary adenoma
Journal
Neurosurgical focus: Video
ISSN: 2643-5217
Titre abrégé: Neurosurg Focus Video
Pays: United States
ID NLM: 101773517
Informations de publication
Date de publication:
Jul 2023
Jul 2023
Historique:
received:
27
02
2023
accepted:
14
04
2023
medline:
7
7
2023
pubmed:
7
7
2023
entrez:
7
7
2023
Statut:
epublish
Résumé
MRI-Negative Cushing disease is a very difficult disease to treat medically and surgically. In the past, after negative gland exploration, hemihypophysectomy was commonly performed on the localizing side of inferior petrosal sampling. However, this generally resulted in 50% remission/cure rates. Therefore, other techniques have arisen based on the percent chance of microadenoma tumor being present in the gland. Subtotal gland resection is a technique aimed at removing 75% of the gland that results in a similar chance of remission and a 10% chance of pituitary dysfunction. In this video, the authors demonstrate this important technique for MRI-Negative Cushing disease. The video can be found here: https://thejns.org/doi/abs/10.3171/2023.4.FOCVID2320.
Identifiants
pubmed: 37416810
doi: 10.3171/2023.4.FOCVID2320
pii: 2023.4.FOCVID2320
pmc: PMC10321549
doi:
Types de publication
Journal Article
Langues
eng
Pagination
V3Informations de copyright
© 2023, The Authors.
Déclaration de conflit d'intérêts
Disclosures Dr. Bancos reported consulting fees from Recordati, Corcept, HRA Pharma, Sparrow, Adrenas, Neurocrine, Spruce, and Diurnal, outside the submitted work.Dr. Bancos reported consulting fees from Recordati, Corcept, HRA Pharma, Sparrow, Adrenas, Neurocrine, Spruce, and Diurnal, outside the submitted work.
Références
World Neurosurg. 2021 Sep;153:e359-e364
pubmed: 34229096
J Neurosurg. 2010 Apr;112(4):750-5
pubmed: 19698042
J Neurosurg. 2018 Nov 1;129(5):1260-1267
pubmed: 29219752
J Clin Endocrinol Metab. 2004 Aug;89(8):3752-63
pubmed: 15292301
J Clin Endocrinol Metab. 2013 Jun;98(6):2285-93
pubmed: 23553862